Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non-Small Cell Lung Cancer

Preclinical studies have shown that peroxisome proliferator-activated receptor γ (PPAR-γ) ligands can exert antitumor effects against non-small cell lung cancer (NSCLC) and a variety of other cancers. In this study, we investigate the potential use of a PPAR-γ ligand, troglitazone (Tro), in combinat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Reddy, Raju C, Srirangam, Anjaiah, Reddy, Kaunteya, Chen, Jun, Gangireddy, Srinivasareddy, Kalemkerian, Gregory P, Standiford, Theodore J, Keshamouni, Venkateshwar G
Formato: Artigo
Lenguaje:Inglês
Publicado: Neoplasia Press Inc. 2008
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2386544/
https://ncbi.nlm.nih.gov/pubmed/18516296
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares